📖
Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m(2) and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial.
Almandoz JP, Miras AD, Blüher M, Orozco Del Pino P, Mojdami D, Batterham RL, Trice K, Goebel B, Tangi F

Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m(2) and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Obes Pillars.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m(2) and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial.
Author / Organization Almandoz JP, Miras AD, Blüher M, Orozco Del Pino P, Mojdami D, Batterham RL, Trice K, Goebel B, Tangi F
Subject & Discipline Obes Pillars
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-116898
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »